Table I.
Patient characteristics (n=37).
| Characteristics | CCRT-alone group | CCRT-CTX group | p-value |
|---|---|---|---|
| Number of patients | 20 | 17 | |
| Median age (years) (range) | 57 (31–72) | 53 (32–72) | |
| FIGO stage | |||
| IB | 2 | 1 | NS |
| IIA | 1 | 0 | |
| IIB | 9 | 7 | |
| IIIA | 1 | 1 | |
| IIIB | 5 | 6 | |
| IVA | 2 | 2 | |
| Histology | |||
| Squamous cell carcinoma | 20 | 13 | 0.036 |
| Non-squamous cell carcinoma | 0 | 4 | |
| No. of pelvic lymph node involvement | |||
| 1 | 4 | 2 | NS |
| 2 | 5 | 3 | |
| 3 | 2 | 5 | |
| ≥4 | 9 | 7 | |
| Para-aortic lymph node involvement | |||
| Positive | 4 | 11 | |
| Negative | 16 | 6 | 0.007 |
| CCRT: Number of CDDP cycles | |||
| 1 | 0 | 1 | NS |
| 2 | 2 | 1 | |
| 3 | 3 | 3 | |
| 4 | 6 | 3 | |
| 5 | 8 | 10 |
CCRT, concurrent chemoradiotherapy; CTX, chemotherapy; NS, not significant; CDDP, cisplatin.